wellabe generates personalized, digital prevention programs based on the most relevant human biomarkers.
wellabe has raised €3.0M across 1 funding round, most recently a Series A round in Dec 2020. Based in Munich, Germany; founded 2018; active in Healthtech. Acquired by Mavie in 2024. Data as of 7 Aug 2026.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-12-04 | Series A | €3.0M | — | View deal → |
